A clinical trial to investigate cemsidomide in combination with other MM agents for earlier lines of treatment in patients with Multiple Myeloma
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Cemsidomide (Primary) ; Antineoplastics
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Jan 2025 New trial record
- 14 Jan 2025 According to C4 Therapeutics media release, this study is expected to initiate in early 2026